|
FDA Estimates Annual IND Safety Reports at 25,000
Safety and adverse event reporting take up the majority of time clinical trial sponsors and investigators devote to reporting and recordkeeping related to IND regulations each year, FDA figures show.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives